Cytomx Therapeutics, Inc. · NASDAQ:CTMX

McCarthy Sean A. sold 101,793 Cytomx Therapeutics, Inc. shares (Form 4/A)

Traded Nov 6, 2025 · Filed Oct 16, 2026

On Nov 6, 2025, McCarthy Sean A. (Director, CEO) sold 101,793 Cytomx Therapeutics, Inc. shares at US$4.54 for US$462K under a trading plan, leaving 1,089,684 shares. Filed Oct 16, 2026 (Form 4/A).

Sold: 101,793 shares
Price: US$4.54
Value: US$462K
Holding after: 1,089,684 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Director, CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Nov 6, 2025	Common Stock	Option exercise	101,793	US$1.59	1,191,477	Direct
Nov 6, 2025	Common Stock	Sale	101,793	US$4.54	1,089,684	Direct

Source

Download original · View original at SEC

Related